ZOMEL

Antiulcer

Esomeprazole

Composition

Each enteric coated tablet contains:
Esomeprazole (as magnesium salt) 20 mg
Excipients q.s.

Each enteric coated tablet contains:
Esomeprazole (as magnesium salt) 40 mg
Excipients q.s.

Bioequivalence: This pharmaceutical product has demonstrated therapeutic equivalence.

Presentations

Zomel 20 mg: Package with 30 enteric-coated tablets
Zomel 40 mg: Package with 30 enteric-coated tablets

Indications

Zomel contains a medicine called esomeprazole which belongs to a group of medicines called 'proton pump inhibitors'. These work by reducing the amount of acid the stomach produces.

Zomel is used to treat the following disorders:
Gastroesophageal reflux disease (GERD):
- Treatment of erosive reflux esophagitis
- Long-term preventive treatment of patients with healed esophagitis to prevent relapse
- Symptomatic treatment of gastroesophageal reflux disease (GERD).
- Use in adolescents from 12 years of age in the short-term treatment of gastroesophageal reflux.

In patients who need continuous treatment with non-steroidal anti-inflammatory drugs (NSAIDs):
- Indicated to reduce the incidence of gastric ulcers associated with continuous therapy with NSAIDs in patients over 18 years of age at risk of developing gastric ulcers. Patients at risk are considered to be those over 60 years of age and/or with a documented history of gastric ulcer.

For patients who require continuous treatment with low-dose aspirin (75-325 mg):
- Prevention of gastric and/or duodenal ulcers associated with low-dose aspirin treatment in patients at risk.

Following treatment with esomeprazole IV for maintenance of hemostasis and prevention of rebleeding of gastric and duodenal ulcers.
In combination with an appropriate antibacterial therapeutic regimen to eradicate Helicobacter pylori and to:
- Scarring of duodenal ulcer associated with Helicobacter pylori and
- Prevention of relapses of peptic ulcers associated with Helicobacter pylori.